Antisulfatide antibodies in neuropathy: Clinical and electrophysiologic correlates

Neurology

Volumn 54, Issue 7, 2000, Pages 1448-1452

  Dabby, R ^a   Weimer, L H ^a   Hays, A P ^a   Olarte, M ^a   Latov, Norman ^a,b  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Antisulfatide antibodies; Axonal neuropathy; Demyelinating; Monoclonal gammopathy; Neuropathy; Small fiber

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN M; SULFIDE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ELECTROPHYSIOLOGY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

EID: 0034636088     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.7.1448     Document Type: Article

References (23)

1. Ilyas AA, Mithen FA, Dalakas MC, et al. Antibodies to sulfated glycolipids in Guillain-Barré syndrome. J Neurol Sci 1991;105:108-117.
2. van den Berg LH, Lankamp CL, de Jager AE, et al. Antisulphatide antibodies in peripheral neuropathy. J Neurol Neurosurg Psychiatry 1993;56:1164-1168.
3. Fredman P, Vedeler CA, Nyland H, Aarli JA, Svennerholm L. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin. J Neurol 1991;238: 75-79.
4. Melendez-Vasquez C, Bedford J, Choudhary PP, et al. Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 1997;73:124-134.
5. Pestronk A, Li F, Griffin J, et al. Polyneuropathy syndromes associated with antibodies to sulfatide and myelin-associated glycoprotein. Neurology 1991;41:357-362.
6. Nemni R, Fazio R, Quattrini A, Lorenzetti I, Mamoli D, Canal N. Antibodies to sulfatide and to chondroitin sulfate C in patients with chronic sensory neuropathy. J Neuroimmunol 1993;43:79-85.
7. Quattrini A, Corbo M, Dhaliwal SK, et al. Anti-sulfatide antibodies in neurological disease: binding to rat dorsal root ganglia neurons. J Neurol Sci 1992;112:152-159.
8. Ryberg B. Multiple specificities of antibrain antibodies in multiple sclerosis and chronic myelopathy. J Neurol Sci 1978;38: 357-382.
9. van Vliet HH, Kappers-Klunne MC, van der Hel JW, Abels J. Antibodies against glycosphingolipids in sera of patients with idiopathic thrombocytopenic purpura. Br J Haematol 1987;67: 103-108.
10. Toda G, Ikeda Y, Kashiwagi M, Iwamori M, Oka H. Hepatocyte plasma membrane glycosphingolipid reactive with sera from patients with autoimmune chronic active hepatitis; its identification as sulfatide. Hepatology 1990;12:664-670.
11. Shigeta H, Yamaguchi M, Nakano K, et al. Serum autoantibodies against sulfatide and phospholipid in NIDDM patients with diabetic neuropathy. Diabetes Care 1997;20:1896-1899.
12. Ilyas AA, Cook SD, Dalakas MC, Mithen FA. Anti-MAG IgM paraproteins from some patients with polyneuropathy associated with IgM paraproteinemia also react with sulfatide. J Neuroimmunol 1992;37:85-92.
13. Nobile-Orazio E, Manfredini E, Carpo M, et al. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 1994;36:416-424.
14. Fredman P, Lycke J, Andersen O, Vrethem M, Ernerudh J, Svennerholm L. Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitope. J Neurol 1993;240:381-387.
15. Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Neurology 1991;41:617-618.
16. Sadiq SA, Thomas FP, Kilidireas K, et al. The spectrum of neurological disease associated with anti-GM1 antibodies. Neurology 1990;40:1067-1072.
17. McGinnis S, Kohriyama T, Yu RK, Pesce MA, Latov N. Antibodies to sulfated glucuronic acid containing glycosphingolipids in neuropathy associated with anti-MAG antibodies and in normal subjects. J Neuroimmunol 1988;17:119-126.
18. Latov N. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies. Ann Neurol 1995;37(S1): S32-S42.
19. van den Berg LH. Neuropathies associated with antisulphatide and other glycoconjugate antibodies. In: Latov N, Wokke JHJ, Kelley JJ Jr, eds. Immunological and Infectious Diseases of the Peripheral Nerves. Cambridge: Cambridge University Press, 1998:201-207.
20. Lopate G, Parks BJ, Goldstein JM, Yee WC, Friesenhahn GM, Pestronk A. Polyneuropathies associated with high titre antisulfatide antibodies: characteristics of patients with and without serum monoclonal proteins. J Neurol Neurosurg Psychiatry 1997;62:581-585.
21. Lopate G, Pestronk A, Kornberg AJ, Yue J, Choksi R. IgM antisulfatide autoantibodies: patterns of binding to cerebellum, dorsal root ganglion and peripheral nerve. J Neurol Sci 1997;151:189-193.
22. Ferrari S, Morbin M, Nobile-Orazio E, et al. Antisulfatide polyneuropathy: antibody mediated complement attack on peripheral myelin. Acta Neuropathol 1998;96:569-574.
23. Nardelli E, Bassi A, Mazzi G, Anzini P, Rizzuto N. Systemic passive transfer studies using IgM monoclonal antibodies to sulfatide. J Neuroimmunol 1995;63:29-37.